SIA expected to recover to pre-COVID levels by FY2024

Pfizer, BioNtech’s latest vaccine developments are a positive news for the airlines.

It will take Singapore Airlines (SIA) at most three years to return to pre-COVID levels, assuming that a vaccine will be ready by mid-2021, according to estimates by OCBC Investment Research.

The airlines’ latest results disappointed analysts, landing significantly below OCBC’s forecasts and Bloomberg’s consensus. The airline’s H1 FY2021 revenue plunged 80.4% YoY to $1.6b on the back of weak passenger flown revenue, partially offset by higher cargo and mail revenue. PATMI reversed from a profit of $205.6m to a record loss of $3.5b during the first half of the year fiscal year due to weak operating performances, fuel hedging ineffectiveness and impairment loss.

There is a light does exist in the end of the tunnel: the announcement of a vaccine by Pfizer and BioNtech. Both vaccines are reportedly at 90% effective, according to latest results. This presents positive news for travel-related stocks, SIA included.

UOB Kay Hian analyst K Ajith also noted that any newsflow of an effective vaccine by end-2020 will aid confidence in SIA stock. Such an event could lead to advance bookings and boost SIA’s chances to raise funds.

“We believe the SIA brand still commands tremendous brand loyalty, which could lead to strong pricing power when demand eventually returns,” Ajith noted.

However, its lack of domestic market meant that its recovery will be at a slower pace. As a result, OCBC Investment Research expects SIA to recover to pre-pandemic levels by FY2024, assuming that a vaccine be available by 2024.

OCBC have raised fair value estimates from $3.5 to $3.7.

Meanwhile, UOB’s Ajith expects SIA to issue $6.2b in mandatory convertible bonds (MCB) by March 2021.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia